المؤلفون: Apostolopoulos V; Institute for Health and Sport, Victoria University, Melbourne, Victoria 3030, Australia; Immunology Program, Australian Institute for Musculoskeletal Science (AIMSS), Melbourne, Victoria 3021, Australia. Electronic address: vasso.apostolopoulos@vu.edu.au., Georgiou N; Laboratory of Organic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimioupolis Zografou, 11571 Athens, Greece. Electronic address: nikitage@chem.uoa.gr., Tzeli D; Laboratory of Physical Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimioupolis Zografou, 11571 Athens, Greece; Theoretical and Physical Chemistry Institute, National Hellenic Research Foundation, 48 Vassileos Constantinou Ave., 11635 Athens, Greece. Electronic address: tzeli@chem.uoa.gr., Mavromoustakos T; Laboratory of Organic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimioupolis Zografou, 11571 Athens, Greece. Electronic address: tmavrom@chem.uoa.gr., Moore GJ; Pepmetics Inc., 772 Murphy Place, Victoria, BC V8Y 3H4, Canada; Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada. Electronic address: mooregj@shaw.ca., Kelaidonis K; NewDrug PC, Patras Science Park, Patras, 26504, Greece., Matsoukas MT; Department of Biomedical Engineering, University of West Attica, Athens 12243, Greece. Electronic address: imats@upatras.gr., Tsiodras S; 4th Department of Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece., Swiderski J; Institute for Health and Sport, Victoria University, Melbourne, Victoria 3030, Australia. Electronic address: jordan.swiderski@live.vu.edu.au., Kate Gadanec L; Institute for Health and Sport, Victoria University, Melbourne, Victoria 3030, Australia. Electronic address: laura.gadanec@live.vu.edu.au., Zulli A; Institute for Health and Sport, Victoria University, Melbourne, Victoria 3030, Australia. Electronic address: anthony.zulli@vu.edu.au., Chasapis CT; Institute of Chemical Biology, National Hellenic Research Foundation, 11635 Athens, Greece. Electronic address: cchasapis@eie.gr., Matsoukas JM; Institute for Health and Sport, Victoria University, Melbourne, Victoria 3030, Australia; Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada; NewDrug PC, Patras Science Park, Patras, 26504, Greece; Department of Chemistry, University of Patras, Patras, Greece. Electronic address: imats1953@gmail.com.

المصدر: Bioorganic chemistry [Bioorg Chem] 2024 Sep; Vol. 150, pp. 107602. Date of Electronic Publication: 2024 Jun 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 1303703 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2120 (Electronic) Linking ISSN: 00452068 NLM ISO Abbreviation: Bioorg Chem Subsets: MEDLINE

مواضيع طبية MeSH: Angiotensin-Converting Enzyme 2*/metabolism , Angiotensin-Converting Enzyme 2*/chemistry , SARS-CoV-2*/drug effects , SARS-CoV-2*/enzymology , Density Functional Theory* , Angiotensin Receptor Antagonists*/pharmacology , Angiotensin Receptor Antagonists*/chemistry, Humans ; Biphenyl Compounds/pharmacology ; Biphenyl Compounds/chemistry ; Antiviral Agents/pharmacology ; Antiviral Agents/chemistry ; Antiviral Agents/chemical synthesis ; COVID-19/virology ; Structure-Activity Relationship ; Molecular Structure ; Benzimidazoles/pharmacology ; Benzimidazoles/chemistry ; Tetrazoles/pharmacology ; Tetrazoles/chemistry ; Tetrazoles/chemical synthesis ; Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Angiotensin-Converting Enzyme Inhibitors/chemistry ; Angiotensin-Converting Enzyme Inhibitors/metabolism ; COVID-19 Drug Treatment

المؤلفون: Bertelmann C; Department of Solar Materials Biotechnology, Helmholtz Centre for Environmental Research GmbH - UFZ, Leipzig, Saxony, Germany.; Department of Microbial Biotechnology, Helmholtz Centre for Environmental Research GmbH - UFZ, Leipzig, Saxony, Germany., Bühler B; Department of Solar Materials Biotechnology, Helmholtz Centre for Environmental Research GmbH - UFZ, Leipzig, Saxony, Germany.; Department of Microbial Biotechnology, Helmholtz Centre for Environmental Research GmbH - UFZ, Leipzig, Saxony, Germany.

المصدر: PloS one [PLoS One] 2024 Sep 06; Vol. 19 (9), pp. e0309965. Date of Electronic Publication: 2024 Sep 06 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Cytochrome P-450 Enzyme System*/metabolism , Cytochrome P-450 Enzyme System*/genetics , Escherichia coli*/metabolism , Escherichia coli*/genetics , Biocatalysis*, Hydroxylation ; Testosterone/metabolism ; Steroids/metabolism ; Bacterial Proteins/metabolism ; Bacterial Proteins/genetics ; NADPH-Ferrihemoprotein Reductase/metabolism ; NADPH-Ferrihemoprotein Reductase/genetics ; Enzyme Stability

المؤلفون: Liu H; School of Science, Xihua University, Chengdu, 610039, China., Liu W; Department of Clinical Laboratory, Zigong First People's Hospital, Zigong, 643000, Sichuan, China., Li Y; School of Science, Xihua University, Chengdu, 610039, China., Jiang X; School of Science, Xihua University, Chengdu, 610039, China., Wang S; School of Science, Xihua University, Chengdu, 610039, China., Zhang G; School of Science, Xihua University, Chengdu, 610039, China. Electronic address: guoqizhangxh@qq.com., Luo X; School of Science, Xihua University, Chengdu, 610039, China. Electronic address: xajunluo@hotmail.com., Zhao Y; School of Science, Xihua University, Chengdu, 610039, China; Asymmetric Synthesis and Chiral Technology Key Laboratory of Sichuan Province, Xihua University, Chengdu, 610039, China. Electronic address: zhao518yan@163.com.

المصدر: Analytica chimica acta [Anal Chim Acta] 2024 Sep 01; Vol. 1320, pp. 343026. Date of Electronic Publication: 2024 Jul 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0370534 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4324 (Electronic) Linking ISSN: 00032670 NLM ISO Abbreviation: Anal Chim Acta Subsets: MEDLINE

مواضيع طبية MeSH: Monophenol Monooxygenase*/antagonists & inhibitors , Monophenol Monooxygenase*/metabolism , Metal-Organic Frameworks*/chemistry , Fluorescent Dyes*/chemistry , Fluorescent Dyes*/chemical synthesis , Enzyme Inhibitors*/pharmacology , Enzyme Inhibitors*/chemistry, Humans ; Spectrometry, Fluorescence ; Limit of Detection ; Enzyme Assays/methods ; Pyrones

المؤلفون: Hashiba S; Drug Metabolism and Toxicology (S.H., Ma.N., I.Y., T.F., Mi.N.) and Pharmaceutical and Health Sciences (H.A.), Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan; WPI Nano Life Science Institute (WPI-NanoLSI) Kanazawa University, Kanazawa, Japan (Ma.N., T.F., Mi.N.); R&D Department, Precision Engineering Center, Industrial Division, Nikkiso Co., Ltd., Kanazawa, Japan (E.T., M.K., Y.J.); and Department of Pharmacokinetics and Nonclinical Safety, Nippon Boehringer Ingelheim Co. Ltd., Kobe, Japan (N.I.)., Nakano M; Drug Metabolism and Toxicology (S.H., Ma.N., I.Y., T.F., Mi.N.) and Pharmaceutical and Health Sciences (H.A.), Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan; WPI Nano Life Science Institute (WPI-NanoLSI) Kanazawa University, Kanazawa, Japan (Ma.N., T.F., Mi.N.); R&D Department, Precision Engineering Center, Industrial Division, Nikkiso Co., Ltd., Kanazawa, Japan (E.T., M.K., Y.J.); and Department of Pharmacokinetics and Nonclinical Safety, Nippon Boehringer Ingelheim Co. Ltd., Kobe, Japan (N.I.) mnakano@staff.kanazawa-u.ac.jp nmiki@p.kanazawa-u.ac.jp., Yokoseki I; Drug Metabolism and Toxicology (S.H., Ma.N., I.Y., T.F., Mi.N.) and Pharmaceutical and Health Sciences (H.A.), Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan; WPI Nano Life Science Institute (WPI-NanoLSI) Kanazawa University, Kanazawa, Japan (Ma.N., T.F., Mi.N.); R&D Department, Precision Engineering Center, Industrial Division, Nikkiso Co., Ltd., Kanazawa, Japan (E.T., M.K., Y.J.); and Department of Pharmacokinetics and Nonclinical Safety, Nippon Boehringer Ingelheim Co. Ltd., Kobe, Japan (N.I.)., Takahashi E; Drug Metabolism and Toxicology (S.H., Ma.N., I.Y., T.F., Mi.N.) and Pharmaceutical and Health Sciences (H.A.), Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan; WPI Nano Life Science Institute (WPI-NanoLSI) Kanazawa University, Kanazawa, Japan (Ma.N., T.F., Mi.N.); R&D Department, Precision Engineering Center, Industrial Division, Nikkiso Co., Ltd., Kanazawa, Japan (E.T., M.K., Y.J.); and Department of Pharmacokinetics and Nonclinical Safety, Nippon Boehringer Ingelheim Co. Ltd., Kobe, Japan (N.I.)., Kondo M; Drug Metabolism and Toxicology (S.H., Ma.N., I.Y., T.F., Mi.N.) and Pharmaceutical and Health Sciences (H.A.), Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan; WPI Nano Life Science Institute (WPI-NanoLSI) Kanazawa University, Kanazawa, Japan (Ma.N., T.F., Mi.N.); R&D Department, Precision Engineering Center, Industrial Division, Nikkiso Co., Ltd., Kanazawa, Japan (E.T., M.K., Y.J.); and Department of Pharmacokinetics and Nonclinical Safety, Nippon Boehringer Ingelheim Co. Ltd., Kobe, Japan (N.I.)., Jimbo Y; Drug Metabolism and Toxicology (S.H., Ma.N., I.Y., T.F., Mi.N.) and Pharmaceutical and Health Sciences (H.A.), Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan; WPI Nano Life Science Institute (WPI-NanoLSI) Kanazawa University, Kanazawa, Japan (Ma.N., T.F., Mi.N.); R&D Department, Precision Engineering Center, Industrial Division, Nikkiso Co., Ltd., Kanazawa, Japan (E.T., M.K., Y.J.); and Department of Pharmacokinetics and Nonclinical Safety, Nippon Boehringer Ingelheim Co. Ltd., Kobe, Japan (N.I.)., Ishiguro N; Drug Metabolism and Toxicology (S.H., Ma.N., I.Y., T.F., Mi.N.) and Pharmaceutical and Health Sciences (H.A.), Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan; WPI Nano Life Science Institute (WPI-NanoLSI) Kanazawa University, Kanazawa, Japan (Ma.N., T.F., Mi.N.); R&D Department, Precision Engineering Center, Industrial Division, Nikkiso Co., Ltd., Kanazawa, Japan (E.T., M.K., Y.J.); and Department of Pharmacokinetics and Nonclinical Safety, Nippon Boehringer Ingelheim Co. Ltd., Kobe, Japan (N.I.)., Arakawa H; Drug Metabolism and Toxicology (S.H., Ma.N., I.Y., T.F., Mi.N.) and Pharmaceutical and Health Sciences (H.A.), Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan; WPI Nano Life Science Institute (WPI-NanoLSI) Kanazawa University, Kanazawa, Japan (Ma.N., T.F., Mi.N.); R&D Department, Precision Engineering Center, Industrial Division, Nikkiso Co., Ltd., Kanazawa, Japan (E.T., M.K., Y.J.); and Department of Pharmacokinetics and Nonclinical Safety, Nippon Boehringer Ingelheim Co. Ltd., Kobe, Japan (N.I.)., Fukami T; Drug Metabolism and Toxicology (S.H., Ma.N., I.Y., T.F., Mi.N.) and Pharmaceutical and Health Sciences (H.A.), Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan; WPI Nano Life Science Institute (WPI-NanoLSI) Kanazawa University, Kanazawa, Japan (Ma.N., T.F., Mi.N.); R&D Department, Precision Engineering Center, Industrial Division, Nikkiso Co., Ltd., Kanazawa, Japan (E.T., M.K., Y.J.); and Department of Pharmacokinetics and Nonclinical Safety, Nippon Boehringer Ingelheim Co. Ltd., Kobe, Japan (N.I.)., Nakajima M; Drug Metabolism and Toxicology (S.H., Ma.N., I.Y., T.F., Mi.N.) and Pharmaceutical and Health Sciences (H.A.), Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan; WPI Nano Life Science Institute (WPI-NanoLSI) Kanazawa University, Kanazawa, Japan (Ma.N., T.F., Mi.N.); R&D Department, Precision Engineering Center, Industrial Division, Nikkiso Co., Ltd., Kanazawa, Japan (E.T., M.K., Y.J.); and Department of Pharmacokinetics and Nonclinical Safety, Nippon Boehringer Ingelheim Co. Ltd., Kobe, Japan (N.I.).

المصدر: Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2024 Aug 14; Vol. 52 (9), pp. 949-956. Date of Electronic Publication: 2024 Aug 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society for Pharmacology and Experimental Therapeutics, etc.] Country of Publication: United States NLM ID: 9421550 Publication Model: Electronic Cited Medium: Internet ISSN: 1521-009X (Electronic) Linking ISSN: 00909556 NLM ISO Abbreviation: Drug Metab Dispos Subsets: MEDLINE

مواضيع طبية MeSH: Kidney Tubules, Proximal*/metabolism , Kidney Tubules, Proximal*/cytology , Kidney Tubules, Proximal*/drug effects , Glucuronosyltransferase*/metabolism , Glucuronosyltransferase*/genetics , Epithelial Cells*/metabolism , Epithelial Cells*/drug effects , Cytochrome P-450 Enzyme System*/metabolism , Cytochrome P-450 Enzyme System*/genetics, Humans ; Cells, Cultured ; Enzyme Induction/drug effects ; Cell Line ; Cell Culture Techniques/methods ; RNA, Messenger/metabolism ; RNA, Messenger/genetics

المؤلفون: Liu X; Department of Analytical Chemistry, China Pharmaceutical University, 24 TongJiaXiang, Nanjing, 210009, Jiangsu, China.; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, Nanjing, 210009, China., Wu J; Department of Analytical Chemistry, China Pharmaceutical University, 24 TongJiaXiang, Nanjing, 210009, Jiangsu, China.; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, Nanjing, 210009, China., Yang S; Department of Analytical Chemistry, China Pharmaceutical University, 24 TongJiaXiang, Nanjing, 210009, Jiangsu, China.; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, Nanjing, 210009, China., Li L; Department of Analytical Chemistry, China Pharmaceutical University, 24 TongJiaXiang, Nanjing, 210009, Jiangsu, China.; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, Nanjing, 210009, China., Ji Y; Department of Analytical Chemistry, China Pharmaceutical University, 24 TongJiaXiang, Nanjing, 210009, Jiangsu, China. jiyibing@msn.com.; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, Nanjing, 210009, China. jiyibing@msn.com.

المصدر: Applied biochemistry and biotechnology [Appl Biochem Biotechnol] 2024 Jul; Vol. 196 (7), pp. 4024-4037. Date of Electronic Publication: 2023 Oct 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Humana Press Country of Publication: United States NLM ID: 8208561 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-0291 (Electronic) Linking ISSN: 02732289 NLM ISO Abbreviation: Appl Biochem Biotechnol Subsets: MEDLINE

مواضيع طبية MeSH: Lipase*/antagonists & inhibitors , Lipase*/chemistry , Enzymes, Immobilized*/chemistry , Enzyme Inhibitors*/chemistry , Enzyme Inhibitors*/pharmacology, Animals ; Swine ; Hydrogen-Ion Concentration ; Metal-Organic Frameworks/chemistry ; Temperature ; Enzyme Stability ; Kinetics

المؤلفون: van der Heijden LT; Department of Pharmacology and Pharmacy, Antoni van Leeuwenhoek/The Netherlands Cancer Institute, Amsterdam, The Netherlands. l.vd.heijden@nki.nl.; Division of Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute, Amsterdam, The Netherlands. l.vd.heijden@nki.nl.; Department of Clinical Pharmacy, OLVG Hospital, Amsterdam, The Netherlands. l.vd.heijden@nki.nl., Opdam FL; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Beijnen JH; Department of Pharmacology and Pharmacy, Antoni van Leeuwenhoek/The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Pharmaco-Epidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands., Huitema ADR; Department of Pharmacology and Pharmacy, Antoni van Leeuwenhoek/The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Pharmacology, Princess Maxima Center, Utrecht, The Netherlands.

المصدر: European journal of drug metabolism and pharmacokinetics [Eur J Drug Metab Pharmacokinet] 2024 Jul; Vol. 49 (4), pp. 407-418. Date of Electronic Publication: 2024 Apr 30.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Springer France Country of Publication: France NLM ID: 7608491 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2107-0180 (Electronic) Linking ISSN: 03787966 NLM ISO Abbreviation: Eur J Drug Metab Pharmacokinet Subsets: MEDLINE

مواضيع طبية MeSH: Cytochrome P-450 Enzyme System*/metabolism , Phenotype* , Drug Interactions*, Humans ; Pharmaceutical Preparations/metabolism ; Pharmaceutical Preparations/administration & dosage ; Animals ; Dose-Response Relationship, Drug ; Cytochrome P-450 Enzyme Inhibitors/pharmacology ; Cytochrome P-450 Enzyme Inhibitors/administration & dosage ; Cytochrome P-450 Enzyme Inhibitors/pharmacokinetics

المؤلفون: Andrianto A; Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.; Department of Cardiology and Vascular Medicine, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia., Hermawan HO; Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.; Department of Cardiology and Vascular Medicine, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia., Harsoyo PM; Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.; Department of Cardiology and Vascular Medicine, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia., Zaini BS; Muhammadiyah Babat General Hospital, Lamongan, Indonesia.; Faculty of Medicine, Universitas Nahdlatul Ulama Surabaya, Surabaya, Indonesia., Muhammad AR; Faculty of Medicine, Universitas Nahdlatul Ulama Surabaya, Surabaya, Indonesia.

المصدر: Narra J [Narra J] 2024 Aug; Vol. 4 (2), pp. e681. Date of Electronic Publication: 2024 Jul 15.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Narra Sains Indonesia Country of Publication: Indonesia NLM ID: 9918625888906676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2807-2618 (Electronic) Linking ISSN: 28072618 NLM ISO Abbreviation: Narra J Subsets: MEDLINE

مواضيع طبية MeSH: Angiotensin-Converting Enzyme 2*/metabolism , Disease Models, Animal* , Interleukin-6*/metabolism , Losartan*/pharmacology , Obesity*/drug therapy , Obesity*/metabolism , Perindopril*/pharmacology , Perindopril*/therapeutic use, Animals ; Male ; Rats ; Adipocytes/drug effects ; Adipocytes/metabolism ; Angiotensin-Converting Enzyme Inhibitors/pharmacology

المؤلفون: Ciuffreda P; Dipartimento di Scienze Biomediche e Cliniche, Università degli Studi di Milano, 20157 Milan, Italy., Xynomilakis O; Dipartimento di Scienze Biomediche e Cliniche, Università degli Studi di Milano, 20157 Milan, Italy., Casati S; Dipartimento di Scienze Biomediche e Cliniche, Università degli Studi di Milano, 20157 Milan, Italy., Ottria R; Dipartimento di Scienze Biomediche e Cliniche, Università degli Studi di Milano, 20157 Milan, Italy.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Jul 13; Vol. 25 (14). Date of Electronic Publication: 2024 Jul 13.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Endocannabinoids*/metabolism , Enzyme Assays*/methods , Amidohydrolases*/metabolism , Amidohydrolases*/antagonists & inhibitors, Humans ; Hydrolysis ; Monoacylglycerol Lipases/metabolism ; Monoacylglycerol Lipases/antagonists & inhibitors ; Animals ; Fluorometry/methods ; Fluorescence ; Kinetics ; Fluorescent Dyes/chemistry ; Enzyme Inhibitors/pharmacology

المؤلفون: Lehner AF; Section of Toxicology, Michigan State University Veterinary Diagnostic Laboratory, Michigan State University, East Lansing, MI, USA., Johnson SD; Department of Veterinary Services, Wildlife World Zoo & Aquarium & Safari Park, Litchfield Park, AZ, USA., Dirikolu L; Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, USA., Johnson M; Section of Toxicology, Michigan State University Veterinary Diagnostic Laboratory, Michigan State University, East Lansing, MI, USA., Buchweitz JP; Section of Toxicology, Michigan State University Veterinary Diagnostic Laboratory, Michigan State University, East Lansing, MI, USA.; Department of Pathobiology & Diagnostic Investigation, College of Veterinary Medicine, Michigan State University, East Lansing, MI, USA.

المصدر: Toxicology mechanisms and methods [Toxicol Mech Methods] 2024 Jul; Vol. 34 (6), pp. 654-668. Date of Electronic Publication: 2024 Feb 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 101134521 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-6524 (Electronic) Linking ISSN: 15376516 NLM ISO Abbreviation: Toxicol Mech Methods Subsets: MEDLINE

مواضيع طبية MeSH: Voriconazole*/pharmacokinetics , Antifungal Agents*/pharmacokinetics , Cytochrome P-450 Enzyme Inhibitors*/pharmacology , Tandem Mass Spectrometry*, Animals ; Cytochrome P-450 Enzyme System/metabolism ; Gas Chromatography-Mass Spectrometry ; Male ; Chromatography, Liquid

المؤلفون: Ha NX; Institute of Natural Products Chemistry, Vietnam Academy of Science and Technology.; Graduate University of Science and Technology, Vietnam Academy of Science and Technology., Huong TT; Institute of Natural Products Chemistry, Vietnam Academy of Science and Technology., Khanh PN; Institute of Natural Products Chemistry, Vietnam Academy of Science and Technology.; Graduate University of Science and Technology, Vietnam Academy of Science and Technology., Hung NP; Institute of Natural Products Chemistry, Vietnam Academy of Science and Technology., Loc VT; Institute of Natural Products Chemistry, Vietnam Academy of Science and Technology., Ha VT; Institute of Natural Products Chemistry, Vietnam Academy of Science and Technology., Quynh DT; Institute of Natural Products Chemistry, Vietnam Academy of Science and Technology., Nghi DH; Institute of Natural Products Chemistry, Vietnam Academy of Science and Technology., Hai PT; University of Science and Technology of Hanoi, Vietnam Academy of Science and Technology., Scarlett CJ; School of Environmental & Life Sciences, College of Engineering, Science and Environment, The University of Newcastle., Wessjohann LA; Department of Bioorganic Chemistry, Leibniz Institute of Plant Biochemistry (IPB)., Cuong NM; Institute of Natural Products Chemistry, Vietnam Academy of Science and Technology.; Graduate University of Science and Technology, Vietnam Academy of Science and Technology.

المصدر: Chemical & pharmaceutical bulletin [Chem Pharm Bull (Tokyo)] 2024 Jun 26; Vol. 72 (6), pp. 574-583. Date of Electronic Publication: 2024 Jun 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Pharmaceutical Society of Japan Country of Publication: Japan NLM ID: 0377775 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1347-5223 (Electronic) Linking ISSN: 00092363 NLM ISO Abbreviation: Chem Pharm Bull (Tokyo) Subsets: MEDLINE

مواضيع طبية MeSH: Glycosides*/chemistry , Glycosides*/pharmacology , Glycosides*/isolation & purification , Angiotensin-Converting Enzyme 2*/metabolism , Angiotensin-Converting Enzyme 2*/antagonists & inhibitors , Angiotensin-Converting Enzyme 2*/chemistry , Molecular Docking Simulation* , Coumarins*/chemistry , Coumarins*/pharmacology , Coumarins*/isolation & purification , SARS-CoV-2*/drug effects , SARS-CoV-2*/enzymology, Humans ; COVID-19/virology ; Rutaceae/chemistry ; COVID-19 Drug Treatment ; Antiviral Agents/pharmacology ; Antiviral Agents/chemistry ; Antiviral Agents/isolation & purification ; Plant Roots/chemistry ; Angiotensin-Converting Enzyme Inhibitors/chemistry ; Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Angiotensin-Converting Enzyme Inhibitors/isolation & purification